Sodium phosphate induced renal failure in patients undergoing colonoscopy with concomitant use of ace inhibitors and diuretics

Boyce, Douglas A; Cannon, Michael
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS105
Academic Journal
An abstract of the article "Sodium Phosphate Induced Renal Failure in Patients Undergoing Colonoscopy With Concomitant Use of Ace Inhibitors and Diuretics" by Douglas A. Boyce and Michael Cannon is presented.


Related Articles

  • ACE Inhibitors Most Effective in Nondiabetic Renal Disease.  // Kidney;Mar/Apr98, Vol. 7 Issue 2, p60 

    Discusses the abstract of the article 'Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials,' by I. Giatras, J. Lau et al, published in the 1997 issue of the 'Annals of Internal Medicine.'

  • Renoprotection: Clues from knockout models of rare diseases. Abbate, Mauro; Remuzzi, Giuseppe // Kidney International;Feb2003, Vol. 63 Issue 2, p764 

    Focuses on the role of defective genes as a central source of information in the field of mechanisms of progression of renal disease. Effect of angiotensin I-converting enzyme (ACE) in patients; Recognition of the fact that prodocyte maintains the integrity of the normal glomerular barrier to...

  • ACE Inhibitors Delay Progress of Renal Disease, Regardless of Severity. Kshirsagar, A.V.; Joy, M.S.; Hogan, S.L. // Kidney;Nov/Dec2000, Vol. 9 Issue 6, p271 

    Provides information on a study which determined the efficacy of angiotensin-converting enzyme inhibitors in slowing the progression of renal disease from any cause over a broad range of functional impairment. Methodology; Results; Conclusion.

  • Digoxin/enalapril/diuretics.  // Reactions Weekly;2/27/2010, Issue 1290, p20 

    The article describes the case of a three-month-old boy with congestive heart failure who developed renal failure while receiving treatment with enalapril and diuretics that led to electrocardiogram abnormalities due to digoxin toxicity.

  • Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Bhattacharjee, Rakesh; Filler, G. // Pediatric Nephrology;Apr2002, Vol. 17 Issue 4, p302 

    Focuses on a study which examined the effect of angiotensin-converting enzyme inhibitor and losartan on immunoglobulin A nephropathy. Indicator of poor prognosis among children; Mechanisms of angiotensin II formation; Discussion of results.

  • ACE inhibitor + ARB therapy: renal toxicity mirrors that seen in RCTs.  // Reactions Weekly;4/16/2011, Issue 1347, p3 

    The article reports on a population-based longitudinal analysis of data from elderly residents of Alberta, Canada which revealed that the hazard ratios for hyperkalaemia and renal dysfunction associated with angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker (ARB)...

  • ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure. Bakris, George L.; Siomos, Martha; Richardson, DeJuran; Janssen, Imke; Bolton, W. Kline; Herbert, Lee; Agarwal, Rajiv; Catazaro, Daniel // Kidney International;Nov2000, Vol. 58 Issue 5, p2084 

    Evaluates the impact of angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) on potassium in renal failure. Decrease of plasma adolsterone; Measurement of serum creatinine level; Incidence of hyperkalemia with ARB; Correlation of serum potassium with adolsterone.

  • An ACE to the rescue. Miller, Albert J.; Grais, I. Martin // Cortlandt Forum;02/25/99, Vol. 12 Issue 2, p155 

    Presents the case of a 70-year old woman with a history of scleroderma-related renal disease and who had been on dialysis in the past. Complaints of progressive and disturbing fatigue; Patchy spinal cord changes; Importance of giving the patient angiotensin-converting enzyme (ACE) inhibitors;...

  • ACE Inhibitor Slows Renal Function Loss.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p10 

    Studies whether angiotensin-converting enzyme inhibitor slows renal function loss. Decline in glomerular filtration rate (GFR) in rampiril and placebo groups; Effectiveness of rampiril in reducing proteinuria and the rate of GFR decline; Reduction in the risk for progression of renal function...

  • ACE Inhibitors May Delay Progression of Sickle Cell Nephropathy.  // Kidney;Nov/Dec98, Vol. 7 Issue 6, p254 

    Presents an abstract of the study 'ACE Inhibitors May Delay Progression of Sickle Cell Nephropathy,' by L. Foucan et al published in a 1998 issue of the 'American Journal of Medicine.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics